Delivery Order SPE2DB22D3301-SPE2DB25FZ0AN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,381.44 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, a broad-spectrum antibiotic commonly used in acute care settings. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,565.69 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 mLS, an antibiotic medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, issued on August 13, 2025, was competitively awarded with no set-aside designation and is scheduled for completion by August 14, 2025. The product will be performed and delivered from AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product valued at $20,952.85. This firm fixed-price delivery order, which has an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose (2 gm/50 mls) with a ceiling value of $31,253.47. This firm fixed-price delivery order, awarded on September 25, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.77 to AmerisourceBergen Drug Corp for Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product used in military healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS. This competitively awarded, firm fixed-price delivery order is valued at $12,695.91 and carries an ultimate completion date of September 5, 2025. The product will be delivered to the Conshohocken, PA location. As a child contract under a larger vehicle,...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,772.27 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,322,209 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,208.89 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,658,119 units of the drug Cefepime-Dextrose 2 GM/50 MLS. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $2,876.94 to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,564,478,187 units of Cefepime-Dextrose 2 gm/50 mL. This order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,903.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4564015152 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0ANDelivery Order
The Defense Logistics Agency awarded a $2,620.75 delivery order to AmerisourceBergen Drug Corp for Cefepime-Dextrose 2 gm/50 mls, an antibiotic solution used in military and federal healthcare settings. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in federal medical procurement through its extensive contract portfolio with the Defense Logistics Agency and related federal healthcare systems. The company's federal contract awards encompass a wide spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA's Medical Supply Chain relies on AmerisourceBergen as a critical vendor to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the agency planning future Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/26/25 |